Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Pharma Clinical Trial Services: World Market 2013-2023

Figure 6.3 Pharma Clinical Trial Services Market: Revenue Forecasts for Leading Therapeutic Areas, 2011, 2017 & 2023

Figure 6.4 Cancer Clinical Trial Services Submarket Forecast, 2011-2023

Figure 6.5 CNS Disease Clinical Trial Services Submarket Forecast, 2011-2023

Figure 6.6 Cardiovascular Disease Clinical Trial Services Submarket Forecast, 2011-2023

Figure 6.7 Chronic Hepatitis B & C: Global Prevalence by Region, 2012

Figure 6.8 Infectious Disease Clinical Trial Services Submarket Forecast, 2011-2023

Figure 6.9 Metabolic Disease Clinical Trial Services Submarket Forecast, 2011-2023

Figure 7.1 The 3+3 Staging Trial Design

Figure 7.2 Growth in the Biomarker Services Market, 2011, 2016 & 2022

Figure 8.1 World CRO Market by Company, 2011

Figure 8.2 Quintiles: Risk-Sharing Partnerships, 2002-2011

Figure 8.3 Covance: Revenue by Sector, 2007-2011

Figure 8.4 Covance: Revenue by Sector, Q1-Q3 2011-2012

Figure 8.5 PPD: Revenue by Sector, Q1-Q2 2010-2011

Figure 8.6 Parexel International: Revenue by Sector, 2010-2012

Figure 8.7 Parexel International: Revenue by Region, 2012

Figure 8.8 ICON: Revenue by Sector, 2010-2011

Figure 8.9 ICON: Revenue by Region, 2011

Figure 8.10 Kendle: Net Service Revenue by Sector, 2010

Figure 8.11 inVentiv Health: Revenue by Sector, Q2 2010 & Q2 2011

Figure 8.12 CMIC: CRO Revenue, 2008-2012

Figure 8.13 Chiltern International's Clinical Trials: Therapeutic Experience

Figure 8.14 Chiltern International: Revenue, 2008-2010

Figure 10.1 Pharma Clinical Trial Services Market by Sector, 2011, 2017 & 2023

Companies Listed

3C Alliance

Agência Nacional de Vigilância Sanitária (ANVISA) [ Brazil]

Agility Clinical

Allscripts

Amgen

Aptuit

ASAN Medical Center

Associação Brasileira de CROs (Abracro)

Association for the Accreditation of Human Research Protection Programs (AAHRPP)

Association of Clinical Trial Organisations (ACTO) [ Russia]

Astellas Pharma

Avista Capital Partners

Bayer

BeijingWits Medical Consulting (part of ICON)

Berry Consultants

BioClinica

BioDuro (part of PPD)

BioDuro Biologics

BioTrak

BML

Boehringer Ingelheim

Bristol- Myers Squibb

Caprion Proteomics

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,387.58 52.30 0.34%
NASDAQ 3,502.12 5.69 0.16%
S&P 500 1,669.16 2.87 0.17%
US 10 Yr 1.944% -0.021

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs